24-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension Patients

Phase 4

Completed

• Conditions: Primary Open Angle Glaucoma; Ocular Hypertension

• Registration Number: NCT00330577
• Lead Sponsor: Aristotle University Of Thessaloniki

Brief Summary

The purpose of this study is to compare the short-term mean 24-hour intraocular pressure control, 24-hour blood pressure effect and safety of Latanoprost/Timolol fixed combination given once in the evening with placebo once in the morning versus timolol maleate 0.5% given twice daily in patients with ocular hypertension and primary open-angle glaucoma.

Detailed Description

Not available

Study Timeline

• Study Start: 2006-04
• Study First Submitted: 2006-05-26
• Study First Submitted QC: 2006-05-26
• Study First Posted: 2006-05-29
• Primary Completion: 2007-04
• Study Completion: 2007-07
• Status Verified: 2014-05
• Last Update Submitted: 2014-05-09
• Last Update Posted: 2014-05-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• POAG
• OHT

Exclusion Criteria

• Advanced glaucoma
• Arterial Hypertension

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Trial Locations

Locations (1)

Glaucoma Unit, A University Dept of Ophthalmology, AHEPA Hospital; 🇬🇷 Thessaloniki, Greece